"Myocardial Ischemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
Descriptor ID |
D017202
|
MeSH Number(s) |
C14.280.647 C14.907.585
|
Concept/Terms |
Myocardial Ischemia- Myocardial Ischemia
- Ischemia, Myocardial
- Ischemias, Myocardial
- Myocardial Ischemias
- Ischemic Heart Disease
- Heart Disease, Ischemic
- Disease, Ischemic Heart
- Diseases, Ischemic Heart
- Heart Diseases, Ischemic
- Ischemic Heart Diseases
|
Below are MeSH descriptors whose meaning is more general than "Myocardial Ischemia".
Below are MeSH descriptors whose meaning is more specific than "Myocardial Ischemia".
This graph shows the total number of publications written about "Myocardial Ischemia" by people in this website by year, and whether "Myocardial Ischemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 |
1998 | 2 | 0 | 2 |
1999 | 1 | 1 | 2 |
2001 | 1 | 0 | 1 |
2002 | 1 | 1 | 2 |
2003 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2005 | 0 | 1 | 1 |
2008 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2013 | 1 | 2 | 3 |
2015 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
2021 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myocardial Ischemia" by people in Profiles.
-
Sex-Specific Considerations in the Presentation, Diagnosis, and Management of Ischemic Heart Disease: JACC Focus Seminar 2/7. J Am Coll Cardiol. 2022 04 12; 79(14):1398-1406.
-
QT Interval Dynamics and Cardiovascular Outcomes: A Cohort Study in an Integrated Health Care Delivery System. J Am Heart Assoc. 2021 10 05; 10(19):e018513.
-
Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort. Gut. 2018 03; 67(3):418-529.
-
Defining a Contemporary Ischemic Heart Disease Genetic Risk Profile Using Historical Data. Circ Cardiovasc Genet. 2016 Dec; 9(6):521-530.
-
Comparisons of sleep apnoea rate and outcomes among patients with resistant and non-resistant hypertension. Respirology. 2016 11; 21(8):1486-1492.
-
Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association. Circulation. 2016 Mar 29; 133(13):1302-31.
-
Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension. Kidney Int. 2015 Sep; 88(3):622-32.
-
Plasma renin activity and its association with ischemic heart disease, congestive heart failure, and cerebrovascular disease in a large hypertensive cohort. J Clin Hypertens (Greenwich). 2014 Nov; 16(11):805-13.
-
Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial). Am J Cardiol. 2013 Dec 01; 112(11):1763-9.
-
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry. Circulation. 2013 Aug 13; 128(7):721-8.